These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3454720)

  • 1. Prevention of pre-eclampsia by early antiplatelet therapy.
    McGarry J; Bickerstaffe R
    Clin Exp Obstet Gynecol; 1987; 14(3-4):131-2. PubMed ID: 3454720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of pre-eclampsia and placental insufficiency.
    Capetta P; Airoldi ML; Tasca A; Bertulessi C; Rossi E; Polvani F
    Lancet; 1986 Apr; 1(8486):919. PubMed ID: 2870389
    [No Abstract]   [Full Text] [Related]  

  • 3. Maternal hemorrhagic complications following prophylactic low-dose aspirin and dipyridamole therapy.
    Reubinoff BE; Eldor A; Laufer N; Sadovsky E
    Gynecol Obstet Invest; 1992; 33(4):241-3. PubMed ID: 1505815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pre-eclampsia by early antiplatelet therapy.
    Beaufils M; Uzan S; Donsimoni R; Colau JC
    Lancet; 1985 Apr; 1(8433):840-2. PubMed ID: 2858710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.
    North RA; Ferrier C; Gamble G; Fairley KF; Kincaid-Smith P
    Aust N Z J Obstet Gynaecol; 1995 Nov; 35(4):357-62. PubMed ID: 8717553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents for preventing pre-eclampsia and its complications.
    Duley L; Henderson-Smart DJ; Knight M; King JF
    Cochrane Database Syst Rev; 2004; (1):CD004659. PubMed ID: 14974075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis.
    Huang J; Chen X; Xing H; Chen L; Xie Z; He S; Wang X; Li Y; Cui H; Chen J
    BMJ Open; 2019 Feb; 9(2):e026920. PubMed ID: 30804037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2000; (2):CD000492. PubMed ID: 10796208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2007 Jul; 2007(2):CD000492. PubMed ID: 17636639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of intrauterine growth retardation and pre-eclampsia by small doses of aspirin. Results of the french multicenter trial EPREDA and comparison with data in the literature; value of uterine Doppler].
    Uzan S; Beaufils M; Bréart G; Uzan M; Paris J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(3):315-8. PubMed ID: 1351078
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective controlled study of early antiplatelet therapy in prevention of preeclampsia.
    Beaufils M; Uzan S; Donsimoni R; Colau JC
    Adv Nephrol Necker Hosp; 1986; 15():87-94. PubMed ID: 3082120
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma.
    Carbonne B; Macé G; Cynober E; Milliez J; Cabane J
    Am J Obstet Gynecol; 2007 Aug; 197(2):e6-7. PubMed ID: 17689619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review.
    Duley L; Henderson-Smart D; Knight M; King J
    BMJ; 2001 Feb; 322(7282):329-33. PubMed ID: 11159655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    Dodd JM; McLeod A; Windrim RC; Kingdom J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006780. PubMed ID: 20556769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe.
    Sotiriadis A
    Ultrasound Obstet Gynecol; 2016 May; 47(5):539-41. PubMed ID: 27147412
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-eclampsia and nasal CPAP: part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for pre-eclampsia: preliminary findings.
    Guilleminault C; Palombini L; Poyares D; Takaoka S; Huynh NT; El-Sayed Y
    Sleep Med; 2007 Dec; 9(1):9-14. PubMed ID: 17644420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of heparin therapy to affect the clinical course of severe pre-eclampsia.
    Howie PW; Prentice CR; Forbes CD
    Br J Obstet Gynaecol; 1975 Sep; 82(9):711-7. PubMed ID: 1182091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
    Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
    Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Theories on the Prevention of Severe Preeclampsia With Low-Molecular Weight Heparin.
    McLaughlin K; Drewlo S; Parker JD; Kingdom JC
    Hypertension; 2015 Dec; 66(6):1098-103. PubMed ID: 26441469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.